Peer Review channel feed

Cyrus Moza­yeni fol­lows ADC 'bea­con' to Pheon CEO role; BeiGene los­es busi­ness chief to Te­va

Last year

Ex­clu­sive: Af­ter Cure­Vac, Ig­or Splaws­ki moves to RTW stealth start­up; Lyn­dra's Jes­si­ca Ballinger adds CEO ti­tle amid com­mer­cial prep

Last year

Deb­o­rah Birx en­ters new phase as biotech CEO; Ve­rastem chief an­nounces his re­tire­ment

Last year

Lynn Seely brings ex-My­ovant col­league to Lyel­l's C-suite; Nkar­ta, Zai Lab name new CFOs

3 years ago

Ex-Gala­pa­gos med­ical chief heads to uniQure; Mar­tin Mack­ay lines up Rally­bio suc­ces­sor

3 years ago

Se­bas­t­ian Guth sharp­ens his fo­cus at Bay­er; As CD47 strug­gles per­sist, I-Mab ap­points CEO

3 years ago

Ex-Metacrine chief Pre­ston Klassen recharges at mi­croR­NA biotech; Al­lo­gene be­gins search for a CFO

3 years ago

Chemomab changes CEOs, sus­pends mid-stage tri­al; Ex-FDA vac­cine of­fi­cial lends more help to Mesoblast

3 years ago

Ex­clu­sive: Affi­ni-T taps Sanofi alum to lead hunt for part­ner­ships; Alk­er­mes locks in CEO for on­col­o­gy spin­out

3 years ago

Stephen Hahn’s can­cer-test­ing biotech hires a new CMO; For­mer Io­vance ex­ec named CEO of Ob­sid­i­an

3 years ago

Vir en­lists J&J vet to run busi­ness de­vel­op­ment; Gilead finds Kite suc­ces­sor to Christi Shaw

3 years ago

Astel­las pres­i­dent jumps to a new Fron­tier; Gri­fols chair­man named CEO, break­ing fam­i­ly tra­di­tion

3 years ago

Maria Fardis ends a two-year CEO hia­tus; More lead­er­ship turnover on the menu at Gala­pa­gos

3 years ago

'In­spired' by Ipsen's mis­sion, San­dra Sil­vestri joins as next CMO; Ex­i­cure's slide con­tin­ues with CEO, CFO ex­its

3 years ago

Amy­lyx wel­comes for­mer Al­ny­lam ex­ec to help ex­pand Re­lyvrio; Amarin plugs in an in­ter­im chief

3 years ago

Leg­end's new CMO will bring in more cell ther­a­py part­ners; Pre­ci­sion founders get back in Tune to­geth­er

3 years ago

Af­ter decades in Big Phar­ma, Kel­ly Page heads to 'growth stage'; Al­lied with No­var­tis, Bi­cy­cle se­lects de­vel­op­ment chief

3 years ago

Jim Mullen scours pri­vate eq­ui­ty deals amid biotech win­ter; Ex-Ab­b­Vie med­ical chief suc­ceeds Brig­gs Mor­ri­son at Syn­dax

3 years ago

Three­'s a crowd as an­oth­er Kite ex­ec hits the ex­it; Surf­ing tough wa­ters, Celyad On­col­o­gy picks up new CEO

3 years ago

Ul­tragenyx adds new CMO with in­ter­nal pro­mo­tion; Au­to­lus CFO to leave for Mor­phoSys — but not quite yet

3 years ago

Bio­gen looks to its bench to re­place chair­man Pa­padopou­los; Lil­ly, Ab­b­Vie gene ther­a­py part­ner makes CSO hire

3 years ago

Kymer­a's top drug hunter leaves for Alex­is Borisy's Curie.Bio; What’s done is Dunn: FDA neu­ro­science leader bows out

3 years ago

Art Levin trades the C-suite for pair of roles at Avid­i­ty; Ex-Mer­ck CEO Ken Fra­zier to chair an­oth­er com­pa­ny

3 years ago

Au revoir, Sanofi: John Reed dash­es to J&J; Zen­tal­is plucks new COO from GSK

3 years ago
First page Previous page 2345678 Next page Last page
A service from the Financial Times